戻る Agenda
Part 3: Submission of the NDA – FDA Review and Actions
Session Chair(s)
Karen K. Church, PHD
Principal
Coachella Valley Regulatory Group, United States
- Electronic Submissions
- FDA review of applications and actions on applications
- Amendments to an unapproved application
- Reasons applications are not approved
- PDUFA